Kotteas E - Search Results

1

CD24: A Novel Target for Cancer Immunotherapy.

Panagiotou E, Syrigos NK, Charpidou A, Kotteas E, Vathiotis IA. Panagiotou E, et al. Among authors: kotteas e. J Pers Med. 2022 Jul 28;12(8):1235. doi: 10.3390/jpm12081235. J Pers Med. 2022. PMID: 36013184 Free PMC article. Review.

2

Targeted therapy for nonsmall cell lung cancer: focusing on angiogenesis, the epidermal growth factor receptor and multikinase inhibitors.

Kotteas EA, Charpidou AG, Syrigos KN. Kotteas EA, et al. Anticancer Drugs. 2010 Feb;21(2):151-68. doi: 10.1097/CAD.0b013e328334da02. Anticancer Drugs. 2010. PMID: 20016368 Review.

3

Immunotherapy for pancreatic cancer.

Kotteas E, Saif MW, Syrigos K. Kotteas E, et al. J Cancer Res Clin Oncol. 2016 Aug;142(8):1795-805. doi: 10.1007/s00432-016-2119-2. Epub 2016 Feb 3. J Cancer Res Clin Oncol. 2016. PMID: 26843405 Review.

4

Treating patients with ALK-rearranged non-small-cell lung cancer: mechanisms of resistance and strategies to overcome it.

Drizou M, Kotteas EA, Syrigos N. Drizou M, et al. Among authors: kotteas ea. Clin Transl Oncol. 2017 Jun;19(6):658-666. doi: 10.1007/s12094-016-1605-y. Epub 2017 Jan 4. Clin Transl Oncol. 2017. PMID: 28054318 Review.

5

Lung Metastasis From Fibrosarcomatous Dermatofibrosarcoma Protuberans of the Vulva: A Rare Case Report.

Vathiotis IA, Psichogiou E, Syrigos KN, Kotteas EA. Vathiotis IA, et al. Among authors: kotteas ea. J Low Genit Tract Dis. 2018 Jan;22(1):85-87. doi: 10.1097/LGT.0000000000000360. J Low Genit Tract Dis. 2018. PMID: 29271862 No abstract available.

6

Prospective Assessment of Clinical Risk Factors and Biomarkers of Hypercoagulability for the Identification of Patients with Lung Adenocarcinoma at Risk for Cancer-Associated Thrombosis: The Observational ROADMAP-CAT Study.

Syrigos K, Grapsa D, Sangare R, Evmorfiadis I, Larsen AK, Van Dreden P, Boura P, Charpidou A, Kotteas E, Sergentanis TN, Elalamy I, Falanga A, Gerotziafas GT. Syrigos K, et al. Among authors: kotteas e. Oncologist. 2018 Nov;23(11):1372-1381. doi: 10.1634/theoncologist.2017-0530. Epub 2018 Aug 13. Oncologist. 2018. PMID: 30104289 Free PMC article.

7

PET/CT and brain MRI role in staging NSCLC: prospective assessment of the accuracy, reliability and cost-effectiveness.

Gkogkozotou VI, Gkiozos IC, Charpidou AG, Kotteas EA, Boura PG, Tsagouli SN, Syrigos KN. Gkogkozotou VI, et al. Lung Cancer Manag. 2018 May 31;7(2):LMT02. doi: 10.2217/lmt-2018-0008. eCollection 2018 Jun. Lung Cancer Manag. 2018. PMID: 30643581 Free PMC article.

8

Towards precision medicine: CCL2, another brick in the wall?

Charpidou A, Kotteas E, Gaga M. Charpidou A, et al. Among authors: kotteas e. Eur Respir J. 2019 Mar 7;53(3):1802327. doi: 10.1183/13993003.02327-2018. Print 2019 Mar. Eur Respir J. 2019. PMID: 30846448 Free article. No abstract available.

9

Orbital metastases of invasive lobular breast carcinoma.

Tsagkaraki IM, Kourouniotis CD, Gomatou GL, Syrigos NK, Kotteas EA. Tsagkaraki IM, et al. Breast Dis. 2019;38(3-4):85-91. doi: 10.3233/BD-190398. Breast Dis. 2019. PMID: 31640079 Review.

10

Do we need prophylactic anticoagulation in ambulatory patients with lung cancer? A review.

Dimakakos E, Kotteas E, Gomatou G, Katsarou T, Vlahakos V, Vathiotis I, Talagani S, Dimitroulis I, Syrigos K. Dimakakos E, et al. Among authors: kotteas e. Vasc Med. 2020 Jun;25(3):255-262. doi: 10.1177/1358863X19899160. Epub 2020 Mar 7. Vasc Med. 2020. PMID: 32146869 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

71 results

Search Page